First Solar: shorts rebuild after earnings drop, Street stays bullish

FSLR heads into the post-earnings period with short sellers adding conviction and the borrow market tightening, even as a Wall Street consensus that remains overwhelmingly positive struggles to move the stock.

Short positioning has quietly intensified. Short interest rose to 8.4% of the free float from 8.2% in the week prior to October 24, adding roughly 190,000 shares net to the short book. That reading, around 9 million shares, is the highest level tracked in this series. Availability sits at 40%, meaning roughly two shares are available in the lending pool for every three already borrowed: tighter than what most lenders would consider comfortable, though not yet at crisis levels. Cost to borrow is 4.73% annualised, down from a spike to 8.46% that ran through the second and third weeks of October. The retreat in borrow cost, even as short interest ticked up, suggests the earlier squeeze on borrow supply has eased somewhat, but the lending market remains meaningfully more constrained than it was a month ago.

Options positioning adds a layer of caution. The put/call ratio at 1.17 is running above its 20-day average of 0.98, though the z-score of 0.81 puts this well short of a panic signal. For context, the 52-week high PCR was 1.74; current hedging activity looks elevated relative to recent norms but not extreme. With utilization at 71% of available borrow, the combined picture is one of a market leaning bearish in a measured rather than aggressive way.

The Street is almost uniformly positive, yet the targets moved mostly in one direction after October 29 earnings. Barclays holds the highest target at $296, with Needham, Truist, Citigroup and Guggenheim all clustered between $265 and $280. However, UBS trimmed from $265 to $250, Piper Sandler cut from $175 to $155, Morgan Stanley moved from $185 to $155, RBC dropped from $300 to $225, KeyBanc from $270 to $225, and Wells Fargo from $290 to $262. Goldman Sachs also nudged its Neutral target down from $175 to $165. Scotiabank initiated with a Sector Outperform and a $215 target on the same day. The consensus average works out to roughly $229. Against an implied US trading price near $146 (inferred from the October 29 insider transactions), that points to around 57% upside to the mean target, a gap wide enough to reflect genuine uncertainty about when, or whether, the stock recovers. No upgrades accompanied the results; the direction of target revisions was almost entirely downward, even among bulls who kept their Buy ratings intact.

The factor picture supports the value case but not the momentum one. FSLR's EV/EBIT rank scores in the 96th percentile of its universe, and earnings yield ranks equally high at 92nd percentile, cheap by two measures that matter for deep-value buyers. The analyst recommendation differential scores at the 92nd percentile, consistent with the broad buy consensus. But short score rank sits in just the 12th percentile, meaning ORTEX's short-positioning model is more bearish on FSLR than on almost 90% of comparable names. EPS momentum over 30 days is middling at the 53rd percentile; over 90 days it drops to the 21st. The stock has gained just 1.1% over the past week and is up less than 1% for the month.

On insider activity, both the CEO and CFO sold shares on October 29, the day of the earnings release. CEO Mark Widmar sold 8,025 shares at $145.91 for proceeds of roughly $1.17 million; CFO Michael Ahearn sold 2,416 shares at the same price for $352,000. Both transactions were executed under 10b5-1 pre-arranged trading plans, which limits their signal value as a real-time sentiment indicator. The same pair executed near-identical plan sales at the end of July and April, confirming this is a scheduled liquidation programme rather than a discretionary decision around the quarter's outcome.

Capital Research and Management stands out among institutional holders, having added 3.7 million shares in the quarter to September 30, bringing its position to 4.1 million shares. That is a very large addition relative to its prior position and makes it the most active buyer among the top-15 holders over the period. BlackRock and State Street both added modestly. The next scheduled earnings event is not until February 23, leaving a long window where the stock's direction will be driven primarily by policy news, order flow updates from management, and any shift in the macro environment for solar.

The central question into that long gap is whether the Street's consensus upside case, built on a backlog, a domestic manufacturing premium, and relatively cheap multiples, can survive continued target trimming without triggering a more serious downgrade cycle.